6220266
Last Update Posted: 2024-05-24
Recruiting
Females accepted | Under |
10 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
The goal of this clinical trial is to learn about the effects of phytoestrogen from Pueraria Mirifica in improvement of serum lipid parameters. The primary question it aims to answer are:
• phytoestrogen from Pueraria Mirifica can reduce serum triglyceride, total cholesterol, LDL and increase HDL or not
Participants will receive capsules which composed of dry weight 50 mg of Pueraria Mirifica twice a day for 2 months. Researchers will compare with diet control\&life style modification to see if there is the improvement of serum lipid parameters
The secondary question it aims to answer are:
* phytoestrogen from Pueraria Mirifica can reduce menopausal symptom score or not * phytoestrogen from Pueraria Mirifica can reduce body mass index(BMI) or not * phytoestrogen from Pueraria Mirifica can reduce waist circumference or not * phytoestrogen from Pueraria Mirifica can reduce blood pressure or not * phytoestrogen from Pueraria Mirifica effects to creatinine, BUN, eGFR or not * phytoestrogen from Pueraria Mirifica effects liver function enzymes or not
Eligibility
Relevant conditions:
Dyslipidemias
Hypertriglyceridemia
Hypercholesterolemia
Hyper-LDL-cholesterolemia
Hypo HDL Cholesterolaemia
Postmenopausal Symptoms
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Contact Information
Overall Contact
Prischa Saengow, MD.
purnprattana@gmail.com
+66-65-2162299
Data sourced from ClinicalTrials.gov